Now you have everything you need to make an informed choice
A review and analysis of seven tirzepatide trials covering up to 72 weeks of treatment found that tirzepatide produced significant, dose-dependent weight loss, with the clearest results emerging as people moved into higher doses
(Its sibling product, Wegovy, contains the same semaglutide but is approved specifically for chronic weight management.) That appetite-taming, stomach-slowing action is exactly why semaglutide is so effective and also why it produces gastrointestinal side effects in some people
You prefer live video consultations with your prescribing provider
Many people look for alternative methods to treat hair loss
Type 2 diabetes can disrupt circulation and metabolic health, limiting the amount of oxygen and nutrients reaching different body parts, including hair follicles